Search company, investor...
iN Therapeutics company logo

iN Therapeutics


Bridge | Alive

Total Raised


Last Raised

$21.68M | 2 yrs ago

About iN Therapeutics

iN Therapeutics is a biotechnology company specializing in new ion channel drug development.

Headquarters Location

South Korea



Latest iN Therapeutics News

Revolutionary mRNA Technology Unlocks a New Era in Therapeutics - Stay Competitive with the mRNA Therapeutics Patent Monitoring Service -

Sep 26, 2023

DUBLIN--(BUSINESS WIRE)--The "Therapeutic mRNA Patent Monitor" newsletter has been added to's offering. The global mRNA therapeutics landscape is experiencing a transformative era, with mRNA-based vaccines leading the way in responding to the COVID-19 pandemic. The remarkable success of these vaccines has not only revolutionized immunization but also brought to the forefront the immense potential of mRNA technology in treating a wide range of diseases and conditions. As t

iN Therapeutics Frequently Asked Questions (FAQ)

  • What is iN Therapeutics's latest funding round?

    iN Therapeutics's latest funding round is Bridge.

  • How much did iN Therapeutics raise?

    iN Therapeutics raised a total of $34.19M.

  • Who are the investors of iN Therapeutics?

    Investors of iN Therapeutics include AJU IB Investment, Shinhan Capital, TIMEFOLIO Asset Management, Yuanta Investment Korea, KIWOOM Investment and 8 more.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.